The article reports a study which found that venous thromboembolism (VTE) risk varied considerably by menopausal hormone therapy (HT) formulation, being greatest in users of oral estrogen-progestin HT, especially formulations containing med...
“When we turn to the biomarker outcomes, we also found a significant association between hormone therapy and primary amyloid outcomes. So, the use of hormone therapy was associated with reduced amyloid burden as measured by [positron emission tomography],” Bruno said. “We found evide...
Hormone Therapy and Risk of Gynecologic Cancers--Reply In Reply: In response to Dr Utian, we acknowledgedthat the estimated effects of estrogen plus progestin on endometrial cancerand ovarian cancer did not rea... GL Anderson - 《Journal of the American Medical Association》 被引量: 2794发表:...
Most researchers have assumed it takes five years of combined-hormone therapy before the overall risk of developing breast cancer is elevated significantly. But the new study found women who took estrogen and progestin every day for as few as three years were about three times more likely to dev...
Purpose This study aimed to use a competing risk approach to evaluate the probability of the occurrence of hormone therapy (HT) interruption and to assess its associated predictors in Asian women with breast cancer. Methods This retrospective cohort study used the Taiwan Health Insurance Research Data...
October 12, 2010 (Chicago, Illinois) — Hormone therapy (HT) increased the risk for coronary heart disease (CHD) in women who had metabolic syndrome at the time they started HT, but had no effect on CHD risk in women without metabolic syndrome, according to new research reported here at ...
Hormone therapy for prostate cancer increases the risk of cardiovascular disease-related death especially in older men, according to a population study involving more than 13,000 patients.
Hormone therapy and risk of cardiovascular outcomes and mortality in women treated with statins This work aims to study the effects of hormone therapy (HT) on the risk of cardiovascular outcomes and all-cause mortality in women treated with statins. W... IA Berglind,M Andersen,A Citarella,.....
Hormone therapy increases risk of ovarian cancerdoi:10.2165/00128415-200912620-00008SpringerReactions Weekly
The association between oral contraceptive (OC) use, hormone replacement therapy (HRT) and lung cancer risk in women is still debated. We performed a pooled analysis of six case–control studies (1961 cases and 2609 controls) contributing to the Internat